Vermont Pricing Disclosures

Vermont Pharmaceutical Marketer Price Disclosure Law

Under Vermont law, pharmaceutical marketers are required to disclose the prices of the drugs they market to Vermont doctors and other persons authorized to prescribe drugs in Vermont.  When disclosing the prices of the drugs they market, the pharmaceutical marketers must also disclose the prices of others drugs in the same therapeutic class.

Below, you will find links to the disclosure forms for each of the pharmaceutical products that Boehringer Ingelheim Pharmaceuticals Inc. markets and for which such disclosure is required.  The disclosures are provided in the format required by the Vermont law and subsequent guidance documents.

The Average Wholesale Price ("AWP") listed for Boehringer Ingelheim Pharmaceuticals, Inc. (“BIPI”) Marketed Products is derived by the third party publisher. BIPI does not set or provide an AWP price to or for any third party publisher, nor does BIPI assign an AWP to any of its products.

Prescription Medicines:

Aggrenox® Catapres® Flomax® Micardis®

Mirapex® Mobic® Persatine® Viramune®

 

© 2008 Boehringer Ingelheim Corporation or an affiliated company. All rights reserved. Use of this site is subject to the terms and conditions set out in the Agreement to use the Boehringer Ingelheim Corporation and its U.S. affiliates' web sites. All content intended for U.S. residents only. Terms of Use and Privacy Policy.